|
Baycol - Pulled from the market by the FDA
Baycol, also called Lipobay (cerivastatin sodium), was manufactured by Bayer AG and was approved in the United States in 1997. Nearly 4 years later in 2001, Baycol was pulled from the market because of severe side effects, serious injury, Rhabdomyolysis, organ damage and death.
Rhabdomyolysis is the breakdown of muscle fibers resulting in the release of muscle fiber contents into the bloodstream, which can be toxic to the kidneys and can result in myoglobinuria and kidney damage. Myoglobin is a damaging oxygen-binding protein pigment found in the skeletal muscle. When the skeletal muscle is damaged, myoglobin is released into the bloodstream. It is filtered out of the bloodstream by the kidneys. Myoglobin breaks down into potentially toxic compounds causing kidney failure.
Symptoms of Rhabdomyolysis include abnormal urine color, muscle tenderness, weakness in the affected muscles, generalized weakness and myalgia (muscle stiffness or aching).
Adverse Effects of Baycol
- Rhabdomyolysis
- Kidney Failure
- Renal Failure
- Hospitalization
- DEATH
Thousands of cases have been and continue to be settled with the drug maker, but time delays are an issue, so please contact us now for a free, private consultation. Our lawyers continue to settle these cases on a ongoing basis.
Your time to collect compensatory and/or punitive damages for your serious injury may be short. If you, a family member or someone you know has been injured after using Baycol, contact us today for a free, private consultation. Knowledge is Power. Let Us Help You Get The Compensation You Deserve.
CLICK HERE to contact us today, or send an email to Info@HelpingTheInjured.com
|
